Literature DB >> 15589019

Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation.

George E Kochiadakis1, Nikos E Igoumenidis, Michail E Hamilos, Panagiotis G Tzerakis, Nikos C Klapsinos, Gregory I Chlouverakis, Panos E Vardas.   

Abstract

This prospective, randomized, single-blinded, placebo-controlled study compared the efficacy and safety of sotalol and propafenone when used for long-term prevention of atrial fibrillation. For the long-term maintenance of normal sinus rhythm, propafenone seems to be more effective than sotalol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589019     DOI: 10.1016/j.amjcard.2004.08.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Rhythm control and cardioversion.

Authors:  N Sulke; F Sayers; G Y H Lip
Journal:  Heart       Date:  2006-09-08       Impact factor: 5.994

2.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

3.  Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system.

Authors:  Suman S Kuppahally; Elyse Foster; Stanford Shoor; Anthony E Steimle
Journal:  Int Arch Med       Date:  2009-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.